Clinical Trials
3 trialsNCT04744116 2026-05-05
Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT06008275 2025-11-10
Neratinib in Combination With Ruxolitinib in Patients With mTNBC
Baylor Research Institute
Phase EARLY_PHASE1 Recruiting
NCT06209606 2024-12-17
Pilot Study Using Changes in Serum BCMA to Determine Disease Progression in Multiple Myeloma
Oncotherapeutics
Phase EARLY_PHASE1 Recruiting